Manufacturers Life Insurance Company, The Travere Therapeutics, Inc. Transaction History

Manufacturers Life Insurance Company, The

$109 Billion
Q4 2024

A detailed history of Manufacturers Life Insurance Company, The transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 27,338 shares of TVTX stock, worth $644,630. This represents 0.0% of its overall portfolio holdings.

Number of Shares

27,338

Previous 47,045 41.89%

Holding current value

$644,630

Previous $658,000 27.66%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$13.65 - $19.85 $269,000 - $391,183	-19,707 Reduced 41.89%	27,338 $476,000
Q3 2024 Nov 13, 2024	BUY	$7.89 - $15.21 $141,475 - $272,730	17,931 Added 61.59%	47,045 $658,000
Q2 2024 Aug 14, 2024	BUY	$5.26 - $8.28 $1,388 - $2,185	264 Added 0.92%	29,114 $239,000
Q1 2024 May 14, 2024	SELL	$7.18 - $9.82 $59,967 - $82,016	-8,352 Reduced 22.45%	28,850 $222,000
Q4 2023 Feb 13, 2024	SELL	$5.44 - $9.5 $1,311 - $2,289	-241 Reduced 0.64%	37,202 $334,000
Q3 2023 Nov 15, 2023	BUY	$7.64 - $17.25 $60,539 - $136,689	7,924 Added 26.84%	37,443 $334,000
Q2 2023 Aug 11, 2023	BUY	$15.3 - $22.61 $77,402 - $114,383	5,059 Added 20.68%	29,519 $453,000
Q1 2023 May 15, 2023	BUY	$17.82 - $22.89 $3,011 - $3,868	169 Added 0.69%	24,629 $553,000
Q4 2022 Aug 11, 2023	SELL	$18.47 - $26.14 $9.59 Million - $13.6 Million	-519,329 Reduced 95.5%	24,460 $514,000
Q4 2022 Feb 13, 2023	SELL	$18.47 - $26.14 $9.59 Million - $13.6 Million	-519,329 Reduced 95.5%	24,460 $514,000
Q3 2022 Aug 11, 2023	SELL	$22.91 - $28.63 $11,546 - $14,429	-504 Reduced 0.09%	543,789 $13.4 Million
Q3 2022 Nov 03, 2022	SELL	$22.91 - $28.63 $11,546 - $14,429	-504 Reduced 0.09%	543,789 $13.4 Million
Q2 2022 Aug 11, 2023	BUY	$20.94 - $30.01 $5,172 - $7,412	247 Added 0.05%	544,293 $13.2 Million
Q2 2022 Aug 15, 2022	BUY	$20.94 - $30.01 $5,172 - $7,412	247 Added 0.05%	544,293 $13.2 Million
Q1 2022 Aug 11, 2023	BUY	$23.61 - $30.6 $12.3 Million - $15.9 Million	519,417 Added 2108.97%	544,046 $14 Million
Q1 2022 May 20, 2022	SELL	$23.61 - $30.6 $128,485 - $166,525	-5,442 Reduced 0.99%	544,046 $14 Million
Q4 2021 Feb 16, 2022	SELL	$24.34 - $31.17 $3.81 Million - $4.88 Million	-156,437 Reduced 22.16%	549,488 $16.9 Million
Q3 2021 Nov 12, 2021	SELL	$12.98 - $25.03 $46,429 - $89,532	-3,577 Reduced 0.5%	705,925 $17.1 Million
Q2 2021 Aug 12, 2021	SELL	$14.11 - $26.4 $22.6 Million - $42.3 Million	-1,600,385 Reduced 69.28%	709,502 $10.4 Million
Q1 2021 May 03, 2021	BUY	$23.37 - $31.77 $2.88 Million - $3.91 Million	123,057 Added 5.63%	2,309,887 $57.7 Million
Q4 2020 Feb 12, 2021	BUY	$19.17 - $27.87 $41.9 Million - $60.9 Million	2,186,830 New	2,186,830 $59.6 Million

Others Institutions Holding TVTX

# of Institutions

213

Shares Held

94.1M

Call Options Held

1.2M

Put Options Held

778K

View Full List

About Travere Therapeutics, Inc.

Ticker TVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,173,600
Market Cap $1.51B
Description
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...

More about TVTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Account

Manufacturers Life Insurance Company, The Travere Therapeutics, Inc. Transaction History